hr and, in the other patient, of an infusion of 8000 CTA units of human plasmin over 30 mm (Table   1 ).
In both instances depletion of antiplasmin activity and systemic fibrinogen degradation were observed. All subjects were given 20 drops of Lugol solution by mouth several hours to I day before the injection of the labeled material and at regular intervals during the course of the study: 5-10 zCi of the labeled material was injected intravenously and blood was drawn into trisodium citrate (final concentration 0.01 M) 10 mm after the injection and twice daily during 6-10 days in the control subjects and several times during the first 3 days inthe patients undergoing thrombolytic therapy. Between 8 and I 5 blood samples were taken from each subject. Pooled urine samples were collected every 24 hr throughout the observation period in four of the control subjects. Plasma (or urine) (2 ml) was pipetted into duplicate For Fig.  lB and 1C) . Upon complete activation, however, a significant part (about 25%) of both the antigen and the radioactivity still migrated in the antiplasmin position (Fig. 1D) . Fig.  2A) . A small For 
Gel filtration
of a mixture of a trace amount of labeled antiplasmin and 3 ml human plasma revealed a main radioactivity peak eluting together with antiplasmm antigen and biologic activity in the albumin position (personal use only. on August 30, 2017. by guest www.bloodjournal.org From 1.0For personal use only. on August 30, 2017. by guest www.bloodjournal.org From
